Whether anything beyond pre-placement ibuprofen reduces IUD placement pain, answered from 2024 federal guidance and randomized trials, is the practice question NU577's evidence summary settles. Searches like "nu 577 unit 8 assignment example", "nu577 unit 8 sample" and "nu577 unit 8 example" land here.
Is Ibuprofen an Hour Before Enough? An Evidence Summary on Pain Control for IUD Placement
[Student Name]
Purdue University Global
NU577: NP II Clinical - Women's Health Focus
Unit 8 Evidence Summary
[Instructor Name]
[Date]
The clinic is a composite; doses and search details are bracketed.
Question
Among patients having an IUD placed, does a [lidocaine] paracervical block, compared with oral NSAIDs alone, reduce pain during placement?
Methods
[PubMed, CINAHL and Cochrane], searched [January 2012 through August 2025]. Admitted: guidelines, systematic reviews and randomized trials in English.
Evidence Table
1. Curtis et al. (2024), the federal practice recommendations. Design: federal practice guidance. Population: all IUD users. Intervention: pain management options. Pain outcome: recommendations. Quality note: the 2024 edition addresses pain management for IUD placement for the first time, drawing on systematic reviews; certainty of underlying evidence often low.
2. Lopez et al. (2015). Cochrane review. Design: systematic review of randomized trials. Population: people having IUDs inserted. Intervention: NSAIDs, lidocaine formulations, misoprostol and others. Pain outcome: pain scores at insertion and after. Quality note: many small trials with varied methods.
3. Mody et al. (2018). Design: randomized controlled trial. Population: [64] nulliparous patients. Intervention: [20 mL of 1% lidocaine] paracervical block against a sham. Pain outcome: pain at placement on a visual analog scale. Quality note: nulliparous only; pain measured at single moments.
Synthesis
Oral NSAIDs taken beforehand do little for the pain of placement itself, while a lidocaine paracervical block may reduce it. The Cochrane review found that NSAIDs did not meaningfully reduce insertion pain, though they may help with cramping afterward (Lopez et al., 2015). The 2018 trial found that a 20 mL paracervical block reduced placement pain in nulliparous patients compared with a sham (Mody et al., 2018). The 2024 guidance states that a paracervical block with lidocaine might reduce pain during placement, and that misoprostol should not be used routinely, since it does not ease placement and causes side effects (Curtis et al., 2024). Certainty is modest.
What the Evidence Cannot Answer
Most trials measured pain at one or two moments and in populations that exclude people with prior trauma, anxiety about pelvic procedures or chronic pelvic pain, for whom pain control may matter most. The block itself involves injections, which some patients may not want. The best approach for those groups is still uncertain.
Recommendation for the Site
1. During placement counseling, describe expected pain truthfully, including cramping at insertion, and offer a paracervical block as an option, with its injections explained.
2. Keep [ibuprofen] for afterward, for cramping, rather than as the only preparation.
3. Do not use misoprostol routinely.
4. Document the patient's choice and her pain afterward, so the site can see whether the change helps.
Barriers
Clinicians not trained in paracervical block need training and supervised practice. Appointment slots may need a few extra minutes. The recommendation is a consideration for the preceptor and clinic leadership.
References
Curtis, K. M., Nguyen, A. T., Tepper, N. K., Zapata, L. B., Snyder, E. M., Hatfield-Timajchy, K., Kortsmit, K., Cohen, M. A., & Whiteman, M. K. (2024). U.S. selected practice recommendations for contraceptive use, 2024. MMWR Recommendations and Reports, 73(3), 1-77. https://doi.org/10.15585/mmwr.rr7303a1
Lopez, L. M., Bernholc, A., Zeng, Y., Allen, R. H., Bartz, D., O'Brien, P. A., & Hubacher, D. (2015). Interventions for pain with intrauterine device insertion. Cochrane Database of Systematic Reviews, 2015(7), Article CD007373. https://doi.org/10.1002/14651858.CD007373.pub3
Mody, S. K., Farala, J. P., Jimenez, B., Nishikawa, M., & Ngo, L. L. (2018). Paracervical block for intrauterine device placement among nulliparous women: A randomized controlled trial. Obstetrics & Gynecology, 132(3), 575-582. https://doi.org/10.1097/AOG.0000000000002790
How this NU577 Unit 8 example is structured
The summary moves from question to answer to recommendation without detours. The PICO line fixes the comparison, so every source is read against the same question. Sources in the table are ordered by strength, guideline first, then systematic review, then trial, and each row's quality note says in a phrase what limits it: small samples, nulliparous populations only, or pain measured at a single moment. The synthesis reconciles them in one paragraph and states the certainty honestly as modest. A separate paragraph addresses what the evidence cannot answer, such as effects in patients with prior trauma or anxiety. The recommendation is written for the site: offer a paracervical block as an option during placement counseling, describe expected pain truthfully, and keep ibuprofen for afterward. Barriers to adopting it, including training and appointment length, close the summary.
Get an NU577 Unit 8 example written to your instructions
Send the practice question your NU577 site raised, or the topic your prompt assigns, with the rubric. The summary that returns states a PICO question, appraises current sources in a table and closes on a recommendation a clinic could adopt, any medication named kept in brackets. The first summary is free and takes 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
NU577 Unit 8 questions, answered
How many sources should an evidence summary include?
Check your rubric, but four to eight is common. Quality matters more than number: a current guideline, a systematic review and two or three trials often answer a practice question well. Include each source's design and limits in the table, and cite the year so a grader can confirm recency.
Does the question have to come from my clinical site?
Many prompts ask for one, because the point is applying evidence to real practice. You can phrase the question in general terms without identifying the site or any patient. If your site raised nothing suitable, a question from your reading that applies to women's health primary care is usually acceptable.
Should the summary recommend a specific drug regimen?
Only as far as the evidence and guidance go, citing where each figure came from. Drug names and amounts in the sample sit inside brackets because the recommendation belongs to an illustration, not to a patient. Your summary should state what the sources support and leave prescribing decisions to the clinicians at your site.